368 related articles for article (PubMed ID: 8062885)
21. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate selectable retroviral vectors for Gaucher disease.
Havenga MJ; Werner AB; Valerio D; van Es HH
Gene Ther; 1998 Oct; 5(10):1379-88. PubMed ID: 9930344
[TBL] [Abstract][Full Text] [Related]
23. High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells.
Correll PH; Colilla S; Dave HP; Karlsson S
Blood; 1992 Jul; 80(2):331-6. PubMed ID: 1627794
[TBL] [Abstract][Full Text] [Related]
24. Effect of cellular type on expression of acid beta-glucosidase: implications for gene therapy in Gaucher disease.
Xu YH; Wenstrup R; Grabowski GA
Gene Ther; 1995 Nov; 2(9):647-54. PubMed ID: 8548554
[TBL] [Abstract][Full Text] [Related]
25. Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA.
Nimgaonkar MT; Bahnson AB; Boggs SS; Ball ED; Barranger JA
Gene Ther; 1994 May; 1(3):201-7. PubMed ID: 7584082
[TBL] [Abstract][Full Text] [Related]
26. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
[TBL] [Abstract][Full Text] [Related]
28. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
29. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease.
Kim EY; Hong YB; Lai Z; Kim HJ; Cho YH; Brady RO; Jung SC
Biochem Biophys Res Commun; 2004 May; 318(2):381-90. PubMed ID: 15120612
[TBL] [Abstract][Full Text] [Related]
30. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
[TBL] [Abstract][Full Text] [Related]
31. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia inhibits Moloney murine leukemia virus expression in activated macrophages.
Puppo M; Bosco MC; Federico M; Pastorino S; Varesio L
J Leukoc Biol; 2007 Feb; 81(2):528-38. PubMed ID: 17062606
[TBL] [Abstract][Full Text] [Related]
33. Expression of the human glucocerebrosidase and arylsulfatase A genes in murine and patient primary fibroblasts transduced by an adeno-associated virus vector.
Wei JF; Wei FS; Samulski RJ; Barranger JA
Gene Ther; 1994 Jul; 1(4):261-8. PubMed ID: 7584090
[TBL] [Abstract][Full Text] [Related]
34. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
[TBL] [Abstract][Full Text] [Related]
35. Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells.
Clapp DW; Freie B; Srour E; Yoder MC; Fortney K; Gerson SL
Exp Hematol; 1995 Jul; 23(7):630-8. PubMed ID: 7601255
[TBL] [Abstract][Full Text] [Related]
36. Transient gene expression mediated by integrase-defective retroviral vectors.
Yu SS; Dan K; Chono H; Chatani E; Mineno J; Kato I
Biochem Biophys Res Commun; 2008 Apr; 368(4):942-7. PubMed ID: 18279658
[TBL] [Abstract][Full Text] [Related]
37. Development of safe and efficient retroviral vectors for Gaucher disease.
Havenga M; Fisher R; Hoogerbrugge P; Roberts B; Valerio D; van Es HH
Gene Ther; 1997 Dec; 4(12):1393-400. PubMed ID: 9472564
[TBL] [Abstract][Full Text] [Related]
38. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.
Fink JK; Correll PH; Perry LK; Brady RO; Karlsson S
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2334-8. PubMed ID: 2315324
[TBL] [Abstract][Full Text] [Related]
39. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
Lieu FH; Hawley TS; Fong AZ; Hawley RG
Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
[TBL] [Abstract][Full Text] [Related]
40. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
Lyons RM; Forry-Schaudies S; Otto E; Wey C; Patil-Koota V; Kaloss M; McGarrity GJ; Chiang YL
Cancer Gene Ther; 1995 Dec; 2(4):273-80. PubMed ID: 8548581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
